Evidence map›Paper›PMID 21688841›Full record

ArticleBioconjugate chemistry2011

Folate receptor-targeted aggregation-enhanced near-IR emitting silica nanoprobe for one-photon in vivo and two-photon ex vivo fluorescence bioimaging.

Xuhua Wang, Alma R Morales, Takeo Urakami, Lifu Zhang, Mykhailo V Bondar, Masanobu Komatsu, Kevin D Belfield

Open access · greenAbstract read
In one paragraph

Article in Bioconjugate chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
10.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 113 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Folate-mediated chemotherapy and diagnostics: An updated review and outlook.Journal of controlled release : official journal of the Controlled Release Society · 2017
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Xuhua WangDepartment of Chemistry, University of Central Florida, Orlando, Florida 32816, United States.
Alma R Morales
Takeo Urakami
Lifu Zhang
Mykhailo V Bondar
Masanobu Komatsu
Kevin D Belfield
University of Central Florida · USSanford Burnham Prebys Medical Discovery Institute · USAnhui Polytechnic University · CNInstitute of Physics · UA

Funding

Normalization of tumor vasculature by R-RasR01CA125255 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI KOMATSU, MASANOBU · 2008 to 2018
$4.2M
Two-Photon Fluorescence Probe Development for in Vivo Spatial and Temporal AngiogR15EB008858 · NIBIB · UNIVERSITY OF CENTRAL FLORIDA · PI BELFIELD, KEVIN D. · 2008 to 2008
$213k
NCI NIH HHS 1 R01 CA125255NCI NIH HHS R01 CA125255NIBIB NIH HHS 1 R15 EB008858-01NIBIB NIH HHS R15 EB008858
6 · The paper itself

Abstract

A two-photon absorbing (2PA) and aggregation-enhanced near-infrared (NIR) emitting pyran derivative, encapsulated in and stabilized by silica nanoparticles (SiNPs), is reported as a nanoprobe for two-photon fluorescence microscopy (2PFM) bioimaging that overcomes the fluorescence quenching associated with high chromophore loading. The new SiNP probe exhibited aggregate-enhanced emission producing nearly twice as strong a signal as the unaggregated dye, a 3-fold increase in two-photon absorption relative to the DFP in solution, and approximately 4-fold increase in photostability. The surface of the nanoparticles was functionalized with a folic acid (FA) derivative for folate-mediated delivery of the nanoprobe for 2PFM bioimaging. Surface modification of SiNPs with the FA derivative was supported by zeta potential variation and (1)H NMR spectral characterization of the SiNPs as a function of surface modification. In vitro studies using HeLa cells expressing a folate receptor (FR) indicated specific cellular uptake of the functionalized nanoparticles. The nanoprobe was demonstrated for FR-targeted one-photon in vivo imaging of HeLa tumor xenograft in mice upon intravenous injection of the probe. The FR-targeting nanoprobe not only exhibited highly selective tumor targeting but also readily extravasated from tumor vessels, penetrated into the tumor parenchyma, and was internalized by the tumor cells. Two-photon fluorescence microscopy bioimaging provided three-dimensional (3D) cellular-level resolution imaging up to 350 μm deep in the HeLa tumor.

Indexed as

Fluorescent DyesFolic AcidNanoparticlesPyransSilicon DioxideAnimalsFemaleFolate Receptors, GPI-AnchoredHeLa CellsHumansMiceMice, NudeMicroscopy, Fluorescence, MultiphotonNeoplasmsFluorescent DyesFolate Receptors, GPI-AnchoredFolic AcidPyransSilicon Dioxide

Identifiers

PMID21688841
PMCPMC3147277
OpenAlexW2143400873

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.